Open beta · everything is free with an account while we build. Founding accounts get preferred pricing when paid plans arrive. Create yours →
ST

SARAH TELLOCK

ACADIA PHARMACEUTICALS · San Diego, CA
Registered · LDAActive
Request introduction →Claim this profile →

At a glance

Works on
Health IssuesMedicare/MedicaidTaxation/Internal Revenue CodeTrade (domestic/foreign)
Professional highlights appear here once this profile is claimed. Claim it →

Background

Career
ACADIA PHARMACEUTICALS
San Diego, CA · current

The past 12 months

Clients
1
past 12 months
Filings
2
past 12 months
Agencies contacted
Food & Drug Administration (FDA)HOUSE OF REPRESENTATIVESSENATETreasury, Dept of

Specific issues

Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267) Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Accelerating Kids Access to Care Act (HR 1509, S 752), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Medicare/Medicaid · 2026 Q2
BINSA Act, H.R. 9102.
Trade (domestic/foreign) · 2026 Q2
Cameron's Law (HR 1414), One Big Beautiful Bill Act (HR 1).
Taxation/Internal Revenue Code · 2026 Q2
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), BINSA Act, H.R. 9102, Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Health Issues · 2026 Q2
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Health Issues · 2026 Q1

Clients

ACADIA PHARMACEUTICALS
2026 · 2 filings
$██,███ / qtrFree in beta

Sources

This profile is built from the public record: filings in the U.S. Senate Lobbying Disclosure Act system. lda.senate.gov ↗

Recent filings2
2026 Q2
ACADIA PHARMACEUTICALS
Q2lda.gov →
2026 Q1
ACADIA PHARMACEUTICALS
Q1lda.gov →